Press Releases

With its continuous focus on Community Outreach initiative, JBCPL hopes to reach out to at least 2.5 Lakh people with its recent programme making a meaningful difference to their lives. Lending a philanthropic hand to people needing help in healthcare, J.B. Chemicals & Pharmaceuticals Limited has partnered with Akshay Chaitanya, an NGO affiliated with the Hare Krishna Movement to provide free lunch for the caretakers of patients in hospitals. Under this initiative of JBCPL, 700 meals will

Click Therapeutics, Inc. (“Click”), a leader in Digital Therapeutics™ as prescription medical treatments, today announced that Randall Stanicky, Chief Financial Officer, will present at Chardan’s Prescription Digital Therapeutics Summit on Monday, April 11, 2022 at 2:30 p.m. ET. Additional information can be found at the event website here. About Click Therapeutics Click Therapeutics, Inc. develops and commercializes softw

Novo Integrated Sciences, Inc., pioneering a holistic approach to patient-first health and wellness through a multidisciplinary healthcare ecosystem of services and product innovation, today announced the Company has completed the acquisition of Clinical Consultants International LLC (“CCI”), a global consulting firm, based in Boca Raton, Florida, specializing in providing value-added services for the pharmaceutical, biotech, healthcare management, hospital management, medical mar

Aizon, an Artificial Intelligence (AI) SaaS provider that transforms pharmaceutical manufacturing operations, and TetraScience, the R&D Data Cloud company, announced today a partnership that will increase customers’ ability to create end-to-end data integrity and speed the delivery of drugs with improved quality and higher output. “Aizon innovates how customers use data to achieve actionable insights within and across manufacturing sites,” says Simon Meffan-Mai

Stilla Technologies, the multiplex digital PCR company, and Promega Corporation today announced a co-marketing agreement that combines sample preparation with the latest Maxwell® systems and digital PCR on the six-color naica® system. With this partnership, the companies will offer an optimized workflow for a wide range of applications including liquid biopsy, sentinel pathogen testing, infectious disease assays, overall cancer research and drug discovery. Representative data of the l

MilliporeSigma, the U.S. and Canada life science business of Merck KGaA, Darmstadt, Germany a leading science and technology company, today announced the acquisition of MAST® (Modular Automated Sampling Technology) platform from Lonza. The MAST® platform is an automated, aseptic bioreactor sampling system designed to advance bioprocessing capabilities for more efficient and cost-effective drug manufacturing. The MAST® platform was developed in Bend, Oregon. The financial details o

ATMPS Ltd/Hataali – the leader in blockchain-based data sharing platforms for advanced therapies – announces it has been granted a patent from the United States Patent and Trademark Office (USPTO) for the use of blockchain technologies in personalised medicines. The company also has applications pending in both Europe and Asia as it looks to cement its technological advantage in the rapidly growing advanced therapy space globally. The new patent comes at a key time for t

Ardelyx, Inc., a specialized biopharmaceutical company focused on developing innovative first-in-class medicines to improve treatment for people with cardiorenal diseases, today announced that the U.S. Food and Drug Administration has approved IBSRELA® (tenapanor), a 50 mg, twice daily oral pill for the treatment of irritable bowel syndrome with constipation (IBS-C) in adults. IBSRELA is a minimally-absorbed small molecule that acts locally in the gastrointestinal (GI) tract to inhibit th

Genialis, a leader in applied data science for the development of precision medicines, today announced it will leverage its proprietary ResponderID AI platform technology to provide retrospective analysis to customers and collaborators to help classify patients for targeted therapy using the OncXerna Xerna™ TME Panel, an RNA-based pan-tumor biomarker shown to be predictive of responses to multiple immune-targeted cancer therapies. Targeted therapies today provide benefit only

Kicking off the season for pharmaceutical professionals to come together digitally (09-27 May, 2022) as well as in-person (17-19 May, 2022). CPHI North America will be held as a SMART event, with three weeks of dedicated pharma learning and partnering. The benefit for the CPHI pharma community, which relies on a widening global supply chain, is that a SMART event format stimulates greater collaboration within the industry. Buyers and sellers are able to actively research new partner